Variant report
Variant | nsv525122 |
---|---|
Chromosome Location | chr11:107761550-107766363 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr11:107764106..107766311-chr11:107767484..107769040,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs553671254 | chr11:107763530-107763531 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs200868460 | chr11:107763548-107763549 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs189385352 | chr11:107763554-107763555 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs554694 | chr11:107763576-107763577 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs475925 | chr11:107763593-107763594 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs192425802 | chr11:107763608-107763609 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs553226310 | chr11:107763637-107763638 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs554251385 | chr11:107763650-107763651 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs183675121 | chr11:107763709-107763710 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs144272495 | chr11:107763753-107763754 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs151056289 | chr11:107763758-107763759 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs374225672 | chr11:107763759-107763760 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs552865 | chr11:107763770-107763771 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs477753 | chr11:107763797-107763798 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs78607269 | chr11:107763807-107763808 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
16 | rs369168142 | chr11:107763812-107763813 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs541739176 | chr11:107763815-107763816 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
18 | rs139790213 | chr11:107763852-107763853 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
19 | rs371310014 | chr11:107763874-107763875 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
20 | rs188395541 | chr11:107763881-107763882 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
21 | rs181220798 | chr11:107763952-107763953 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
22 | rs570168328 | chr11:107764014-107764015 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
23 | rs151314691 | chr11:107764020-107764021 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs374300340 | chr11:107764021-107764022 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs141580292 | chr11:107764023-107764024 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
26 | rs79835383 | chr11:107764024-107764025 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
27 | rs370152521 | chr11:107764025-107764026 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
28 | rs530909850 | chr11:107764046-107764047 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
29 | rs552306128 | chr11:107764065-107764066 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
30 | rs543494225 | chr11:107764081-107764082 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
31 | rs34463774 | chr11:107764154-107764155 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs185865886 | chr11:107764155-107764156 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
33 | rs732098 | chr11:107764164-107764165 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | mRNA abundance |
34 | rs113892665 | chr11:107764165-107764166 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
35 | rs553689854 | chr11:107764169-107764170 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
36 | rs12099420 | chr11:107764172-107764173 | Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs577124209 | chr11:107764175-107764176 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
38 | rs554077701 | chr11:107764226-107764227 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs118024459 | chr11:107764247-107764248 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs575747389 | chr11:107764320-107764321 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs190150563 | chr11:107764341-107764342 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs558245035 | chr11:107764375-107764376 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs182325454 | chr11:107764460-107764461 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs546063554 | chr11:107764478-107764479 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs149919931 | chr11:107764509-107764510 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs115781346 | chr11:107764510-107764511 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs57289253 | chr11:107764528-107764529 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs536006734 | chr11:107765085-107765086 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs547965640 | chr11:107765128-107765129 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs542388369 | chr11:107765153-107765154 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Cervical cancer | 21062161 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 22429812 | CNVD |
Breast cancer | 16608533 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21958427 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 17603634 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Basal cell lymphoma | 16790693 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Breast cancer | 21364760 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Mental retardation | 19966786 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Chronic lymphocytic leukemia | 17805327 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Breast cancer | 16397240 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 18632612 | CNVD |
Obesity | 19966786 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Cancer | 20164920 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Attention deficit hyperactivity disorder | 19546859 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:107763400-107763800 | Enhancers | HMEC | breast |
2 | chr11:107763600-107763800 | Enhancers | NHEK | skin |
3 | chr11:107763600-107764600 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
4 | chr11:107763800-107764200 | Flanking Active TSS | HMEC | breast |
5 | chr11:107763800-107764200 | Flanking Active TSS | NHEK | skin |
6 | chr11:107763800-107764400 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
7 | chr11:107763800-107764600 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
8 | chr11:107764200-107764400 | Enhancers | HMEC | breast |
9 | chr11:107764200-107764400 | Enhancers | NHEK | skin |
10 | chr11:107765000-107765200 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |